Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes-A meta-analysis

作者：Xu, Kuanfeng; Zha, Min; Wu, Xiaohong; Yu, Zhangbin; Yu, Rongbin; Xu, Xinyu; Chen, Heng; Yang, Tao^*

来源：Diabetes Research and Clinical Practice, 2011, 91(2): 195-202.

DOI：10.1016/j.diabres.2010.11.012

• SLC30A8
• Type 2 diabetes
• Type 1 diabetes
• Impaired glucose tolerance
• Meta-analysis

Aims: To investigate the association of solute carrier family 30 member 8 (SLC30A8) rs13266634 C/T polymorphism with type 2 diabetes (T2DM), impaired glucose tolerance (IGT), and type 1 diabetes (T1DM). @@@ Methods: We searched all the publications about the association between SLC30A8 and diabetes from PubMed, and evaluated the association between SLC30A8 rs13266634 C/T polymorphism and T2DM, IGT and T1DM, respectively, by meta-analysis of all the validated studies. Allelic and genotypic comparisons between cases and controls were evaluated. @@@ Results: Thirty six studies were included in the meta-analysis: 31 studies were analysed for rs13266634 C/T polymorphism with T2DM, 3 studies with IGT and 4 studies with T1DM. The pooled odds ratios (ORs) for allelic and genotypic comparisons (including additive model, co-dominant model, dominant model and recessive model) showed that rs13266634 C/T polymorphism was significantly associated with increased T2DM risk: OR = 1.15, 95% confidence interval (CI) = 1.13-1.17, P < 0.001, P-heterogeneity = 0.041, OR = 1.34, 95% CI = 1.26-1.41, P < 0.001, P-heterogeneity = 0.908, OR = 1.20, 95% CI = 1.16-1.24, P < 0.001, Pheterogeneity = 0.699, and OR = 1.23, 95% CI = 1.17-1.30, P < 0.001, P-heterogeneity = 0.801, respectively. In subgroup analyses, we found that rs13266634 C/T polymorphism was associated with T2DM risk both in Asian and European subgroup (P < 0.001), but not in African (P > 0.05). And the pooled odds ratio (OR) for allelic frequency comparison showed that rs13266634 C/T polymorphism was also significantly associated with IGT: OR = 1.15, 95% CI = 1.06-1.26, P < 0.001, Pheterogeneity = 0.364. Meanwhile, our meta-analysis did not suggest that rs13266634 C/T polymorphism was associated with T1DM risk (P > 0.05): OR = 1.02, 95% CI = 0.98-1.06, P = 0.328, Pheterogeneity = 0.488 for allelic frequency comparison. @@@ Conclusions: Our meta-analysis results revealed the significant association between rs13266634 C/T polymorphism and T2DM and IGT, but did not support the association between this polymorphism and T1DM.

• 出版日期2011-2
• 单位南京医科大学